Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 3,236

Document Document Title
WO/2007/105668A1
The invention provides a novel immobilized Lewis acid catalyst which exhibits high catalytic activity in an aqueous solution and which permits recovery and reuse or long-term continuous use. The invention relates to an immobilized Lewis ...  
WO2006134457A8
Synthesis of 2,5-bis-diamine-[l,4]benzoquinonic derivatives having the general formula (I), products and intermediates of said synthesis; the synthesis involves the use of p-benzoquinones having the general formula (IX) and diamines havi...  
WO/2007/077111A1
Compounds having bi-cyclic structure comprising a partially unsaturated 6-carbon first cyclic moiety interconnected to a 6-carbon second cyclic moiety second via a divalent linking moiety are provided. The compounds can be used as interm...  
WO/2007/054254A1
The invention related to a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren. Inter alia, the invention relates to a pr...  
WO/2007/049579A1
Disclosed is a photopolymerizable composition containing a squarylium compound represented by the general formula (I) below, a radical initiator and a compound having an ethylenically unsaturated double bond. (I) [In the formula, R1 and ...  
WO/2007/011005A1
A process for producing a biaryl compound, comprising reacting an aromatic organic compound with at least one compound selected from the group consisting of an aromatic organoboron compound and a boroxin ring compound in the presence of ...  
WO/2007/007791A1
A process for the decomposition and recovery of isocyanate compounds which comprises introducing continuously an isocyanate compound having at least one isocyanate group or at least one group derived from an isocyanate group in a molten ...  
WO/2007/002597A3
The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the ...  
WO/2007/000918A1
Benzylamine derivatives having structures represented by the general formula (1): (1) a method for the optical resolution of benzylamine derivatives which comprises using optically active mandelic acid as the reagent for optical resoluti...  
WO/2006/134457A2
Synthesis of 2,5-bis-diamine-[l,4]benzoquinonic derivatives having the general formula (I), products and intermediates of said synthesis; the synthesis involves the use of p-benzoquinones having the general formula (IX) and diamines havi...  
WO2006085049A3
A pro-odorant or pro-flavorant having the formula (I): wherein R1 is H, an aliphatic group or an aromatic group, R2 is an aliphatic group or an aromatic group, provided that the total number of carbon atoms in the groups R1 and R2 is 10 ...  
WO2006085048A3
A pro-odorant or pro-flavorant that is liquid at room temperature and has a relatively low viscosity and has the formula (I): wherein R1 is H, an aliphatic group or an aromatic group, R2 is an aliphatic group or an aromatic group, provid...  
WO/2006/134457A3
Synthesis of 2,5-bis-diamine-[l,4]benzoquinonic derivatives having the general formula (I), products and intermediates of said synthesis; the synthesis involves the use of p-benzoquinones having the general formula (IX) and diamines havi...  
WO/2006/128802A3
The present invention relates to compounds of formula (I) wherein R1, R2 and R3 are as defined hereinabove which are active at the GABAB receptor and which can be used for the preparation of medicaments useful in the control or preventio...  
WO/2006/128802A2
The present invention relates to compounds of formula (I) wherein R1, R2 and R3 are as defined hereinabove which are active at the GABAB receptor and which can be used for the preparation of medicaments useful in the control or preventio...  
WO/2006/126086A3
This invention relates to a process for the synthesis of ketomethylene derivatives of the tripeptide Phe-Gly-Pro ("keto-ACE", compound 5a) and analogues thereof. The synthesis process proceeds via an α,ß-unsaturated keto intermediate. ...  
WO/2006/125397A1
Nonsteroic androgen acceptor regulator compounds of the general formula (I), pharmaceutically acceptable salts thereof, preparation process and pharmaceutically compositions containing the said compounds are disclosed. Such compounds of ...  
WO/2006/126086A2
This invention relates to a process for the synthesis of ketomethylene derivatives of the tripeptide Phe-Gly-Pro ("keto-ACE", compound 5a) and analogues thereof. The synthesis process proceeds via an α,ß-unsaturated keto intermediate. ...  
WO2005119315A3
In one aspect, the present invention provides a hyperpolarizable organic chromophore. The chromophore is a nonlinear optically active compound that includes a p-donor conjugated to a p-acceptor through a p-electron conjugated bridge. In ...  
WO2006079090A3
Methods and intepnediates for the preparation of Fenoldopam mesylate and ntermediates thereof are provided.  
WO2005080314B1
A process for the preparation of compound AQ4N of formula (2) or a salt or solvate thereof wherein the said process includes the reaction step: Formula (1), Formula (2), where compound AQ4 of formula (1) is oxidised to compound AQ4N of f...  
WO/2006/091301A2
Protecting the security of an entity by using passcodes is disclosed. A passcode device 101 generates a passcode Pi. In an embodiment, the passcode Pi is generated in response to receipt of user information. The passcode Pi 1 is received...  
WO2006019955A3
Disclosed herein are antiviral compounds, such as anti-human cytomegalovirus antiviral compounds, pharmaceutical compositions and antiviral methods.  
WO/2006/087166A1
Provided is a process for the preparation of N-monosubstituted β-aminoalcohol sulfonates of formula (Ia), (Ib) wherein R1 is C6-20 aryl or C4-12 heteroaryl, each optionally being substituted with one or more halogen atoms and/or one or ...  
WO/2006/085049A2
A pro-odorant or pro-flavorant having the formula (I): wherein R1 is H, an aliphatic group or an aromatic group, R2 is an aliphatic group or an aromatic group, provided that the total number of carbon atoms in the groups R1 and R2 is 10 ...  
WO/2006/085048A2
A pro-odorant or pro-flavorant that is liquid at room temperature and has a relatively low viscosity and has the formula (I): wherein R1 is H, an aliphatic group or an aromatic group, R2 is an aliphatic group or an aromatic group, provid...  
WO/2006/079090A2
Methods and inte&pgr nediates for the preparation of Fenoldopam mesylate and ntermediates thereof are provided.  
WO/2006/072785A3
The present invention relates to novel base stable ionic liquids and uses thereof as solvents in chemical reactions, especially base catalysed chemical reactions and reactions comprising the use of strong basis.  
WO/2006/072785A2
The present invention relates to novel base stable ionic liquids and uses thereof as solvents in chemical reactions, especially base catalysed chemical reactions and reactions comprising the use of strong basis.  
WO/2006/072354A1
The invention relates to novel squaric acid compounds of formula (I) wherein R, Rl, R1', R2 and X have the designations cited in patent claim (1). Said compounds are SGK inhibitors and can be used to treat SGK-related diseases and illnes...  
WO/2006/069798A1
The invention relates to a process for the preparation of a chiral amine, whereby a ketone or aldehyde is contacted with an enantiomerically enriched phenylglycine amide to give an imine, whereby the imine is subsequently contacted with ...  
WO2005108347A3
The invention relates to substituted enaminones of Formula (I) and their derivatives and the discovery that these compounds modulate the effect of ?-aminobutyric acid (GABA) on the GABAA receptor complex in a therapeutically relevant fas...  
WO/2006/057323A1
A composition for amyloid-associated disease diagnosis, comprising any of a flavone derivative, a chalcone derivative, a styrylchromone derivative and a coumarin derivative. These derivative compounds simultaneously have a high binding s...  
WO2005070869A8
The present invention describes an improved catalyst and process for the selective hydrogenation of nitro aromatics, nitrosoaromatics and aromatic hydroxyl amines to their corresponding amines using gaseous hydrogen, in the presence of s...  
WO/2006/019955A2
Disclosed herein are antiviral compounds, such as anti-human cytomegalovirus antiviral compounds, pharmaceutical compositions and antiviral methods.  
WO/2006/003220A1
The invention relates to a method of preparing 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles having formula (I), wherein the asterisk (*) represents an asymmetrical carbon and R1 is alkyl C1-C6, the enantiomers or mixtures there...  
WO/2005/119315A2
In one aspect, the present invention provides a hyperpolarizable organic chromophore. The chromophore is a nonlinear optically active compound that includes a &pgr -donor conjugated to a &pgr -acceptor through a &pgr -electron conjugated...  
WO/2005/118524A1
A preparation method of [(S)-(-)-alpha-methylamino phenylacetone ]2 (2R,3R)­-tartaric acid derivates is disclosed, which comprises forming salt from (±) -alpha­methylamino phenylacetone, (R)-(+)-alpha-methylamino phenylacetone or (±)...  
WO/2005/116054A1
Disclosed are highly convergent processes for preparing compounds of formula (I), which compounds are potent active agents for the treatment of hepatitis C virus (HCV) infection. The disclosed processes use SNAr-type coupling reactions b...  
WO2005080314A3
A process for the preparation of compound AQ4N of formula (2) or a salt or solvate thereof wherein the said process includes the reaction step: Formula (1), Formula (2), where compound AQ4 of formula (1) is oxidised to compound AQ4N of f...  
WO2004026804A8
The invention provides novel anthraquinone compositions that are useful as broad-spectrum quenchers of fluorescence and provides methods for making and using them. The anthraquinone quenchers can be conjugated to a variety of biologicall...  
WO/2005/108347A2
The invention relates to substituted enaminones of Formula (I) and their derivatives and the discovery that these compounds modulate the effect of &gammad -aminobutyric acid (GABA) on the GABAA receptor complex in a therapeutically relev...  
WO2004083336A3
The present invention provides functional finishing dyes comprising at least one functional finishing group covalently attached to a traditional dye via a chemical linkage. More particularly, the present invention provides novel antimicr...  
WO/2005/099688A3
There is provided a CRF receptor antagonist comprising a compound of the formula (I): A-W-Ar wherein, A is a group represented by the formula (A1) or (A2) (wherein, ring Aa is a 5-or 6-membered ring which may be further substituted; ring...  
WO/2005/099688A2
There is provided a CRF receptor antagonist comprising a compound of the formula (I): A-W-Ar wherein, A is a group represented by the formula (A1) or (A2) (wherein, ring Aa is a 5-or 6-membered ring which may be further substituted; ring...  
WO/2005/100300A1
A 5-aminolevulinic acid salt which is useful in the fields of microorganisms, fermentation, animals, medical science, plants and so on; a process for producing the same; a medicinal composition containing the same; and a plant vitalizer ...  
WO/2005/084803A1
[PROBLEMS] To provide an asymmetric reaction catalyst which is excellent in yield and stereoselectivity and easy of handling and a process for the production of optically active compounds with the same. [MEANS FOR SOLVING PROBLEMS] An as...  
WO2005063665B1
The invention provides para substituted dialkylphenol derivatives of propofol. The invention further provides pharmaceutical compositions comprising such analogs, methods for preparing such analogs, and methods of using such analogs to i...  
WO/2005/080315A1
The invention relates to (3,5-diaminophenyl)(2,4-dihydroxyphenyl)methanone and to its acid adducts of formula (I), in which 0 = n = 2 and HX stands for an inorganic or organic acid. The invention also relates to colorants containing said...  
WO/2005/080314A2
A process for the preparation of compound AQ4N of formula (2) or a salt or solvate thereof wherein the said process includes the reaction step: Formula (1), Formula (2), where compound AQ4 of formula (1) is oxidised to compound AQ4N of f...  

Matches 201 - 250 out of 3,236